Overview
Haiyan Zeng practices in Chengdu, China. Zeng is highly rated in 3 conditions, according to our data. Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Brain Tumor.
Their clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Small Cell Lung Cancer (SCLC)Zeng isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Lung CancerZeng isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Brain TumorZeng isExperienced. Learn about Brain Tumor.
- Metastatic Brain TumorZeng isExperienced. Learn about Metastatic Brain Tumor.
- Rosai-Dorfman DiseaseZeng isExperienced. Learn about Rosai-Dorfman Disease.